Skip to main content
Clinical Trials/NCT05939518
NCT05939518
Completed
Not Applicable

The Contribution of Liberal Fluid Therapy to Glycocalyx Shedding, Interstitial Edema and Fluid Accumulation During Moderate Surgery

Hadassah Medical Organization1 site in 1 country51 target enrollmentMay 13, 2020
ConditionsAbdominoplasty

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Abdominoplasty
Sponsor
Hadassah Medical Organization
Enrollment
51
Locations
1
Primary Endpoint
Change from preoperative serum concentration of Syndecan-1.
Status
Completed
Last Updated
last year

Overview

Brief Summary

Goal-directed fluid therapy is one of the most accepted strategies in intraoperative fluid therapy, although potential fluid overload is a possible drawback. Fluid overload has recently been shown to cause damage to the glycocalyx and to increase extravasation of fluids into the interstitial space.

This study aims to determine whether liberal fluid administration during moderate surgery results in impairment to the endothelial glycocalyx and causes edema.

Participants will be randomized to receive either a liberal or restrictive fluid protocol with vasopressor support. The investigators will measure interstitial edema by clinical signs, pulmonary congestion by ultrasound, and extracellular water by bioimpedance. Impairment of glycocalyx will be estimated by measuring blood levels of shedding markers. In addition, wound healing and early postoperative outcome will be estimated by POMS.

Registry
clinicaltrials.gov
Start Date
May 13, 2020
End Date
August 3, 2023
Last Updated
last year
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Patients scheduled for abdominoplasty.
  • American Society of Anesthesiologists Classification 1 or 2.

Exclusion Criteria

  • Pregnancy.

Outcomes

Primary Outcomes

Change from preoperative serum concentration of Syndecan-1.

Time Frame: Two hours after completion of surgery.

Measured using blood samples drawn from a peripheral vein of the study participant and analyzed in a laboratory.

Change from preoperative serum concentration of Heparan Sulfate.

Time Frame: Two hours after completion of surgery.

Measured using blood samples drawn from a peripheral vein of the study participant and analyzed in a laboratory.

Change from preoperative serum concentration of Sphingosine-1-Phosphate.

Time Frame: Two hours after completion of surgery.

Measured using blood samples drawn from a peripheral vein of the study participant and analyzed in a laboratory.

Early appearance of peripheral pitting edema.

Time Frame: Two hours after completion of surgery.

Bilateral physical examination of the study participant's wrists and ankles, performed by a physician.

Late appearance of peripheral pitting edema.

Time Frame: During the first postoperative day.

Bilateral physical examination of the study participant's wrists and ankles, performed by a physician.

Late change in the percentage of Total Body Water and Extracellular Water.

Time Frame: Two hours after completion of surgery.

Measured by bioimpedance using a commercially available device connected to the study participant.

Change from preoperative serum concentration of Hyaluronic Acid.

Time Frame: Two hours after completion of surgery.

Measured using blood samples drawn from a peripheral vein of the study participant and analyzed in a laboratory.

Appearance of B-lines on lung ultrasonography.

Time Frame: Two hours after completion of surgery.

Bilateral ultrasonography of the study participant's lungs, performed by a physician using two views: posterior and lateral.

Early change in the percentage of Total Body Water and Extracellular Water.

Time Frame: Immediately after completion of surgery.

Measured by bioimpedance using a commercially available device connected to the study participant.

Postoperative Morbidity Survey (POMS) Score.

Time Frame: During the first postoperative day.

Clinically evaluated by a physician for each study participant.

Secondary Outcomes

  • Change from preoperative body weight.(During the first postoperative day.)
  • Volume of urine produced during the procedure.(Immediately after completion of surgery.)
  • Early change from preoperative Cardiac Output.(Immediately after completion of surgery.)
  • Early change from preoperative serum concentration of C-Reactive Protein.(Immediately after completion of surgery.)
  • Late change from preoperative serum concentration of C-Reactive Protein.(Two hours after completion of surgery.)
  • Early change from preoperative serum concentration of Lactate.(Immediately after completion of surgery.)
  • Change from preoperative serum concentration of Creatinine.(Immediately after completion of surgery.)
  • Change from preoperative Mean Arterial Blood Pressure.(Immediately after completion of surgery.)
  • Change from preoperative serum concentration of Hemoglobin.(Immediately after completion of surgery.)
  • Change from preoperative Heart Rate.(Immediately after completion of surgery.)
  • Late change from preoperative Cardiac Output.(Two hours after completion of surgery.)
  • Late change from preoperative serum concentration of Lactate.(Two hours after completion of surgery.)

Study Sites (1)

Loading locations...

Similar Trials